Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R-ACVBP vs R-CHOP in Young Patients with DLBCL
NCT00140595Phase 3Completed
- Sponsor
- Lymphoma Study Association
- Start
- Dec 2003
- Primary completion
- Jan 2009
- Modality
- Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of vindesine, bleomycin in diffuse large B-cell lymphoma (DLBCL), sponsored by Lymphoma Study Association. Started Dec 2003; status: completed.
02
Drugs
vindesinebleomycin
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT00140595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00140595.